268 related articles for article (PubMed ID: 11716041)
1. Computer-assisted cell morphometry and ploidy analysis in the assessment of thyroid follicular neoplasms.
Frasoldati A; Flora M; Pesenti M; Caroggio A; Valcavil R
Thyroid; 2001 Oct; 11(10):941-6. PubMed ID: 11716041
[TBL] [Abstract][Full Text] [Related]
2. One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma.
Mihai R; Parker AJ; Roskell D; Sadler GP
Thyroid; 2009 Jan; 19(1):33-7. PubMed ID: 18976164
[TBL] [Abstract][Full Text] [Related]
3. Detection of underlying characteristics of nuclear chromatin patterns of thyroid tumor cells using texture and factor analyses.
Murata S; Mochizuki K; Nakazawa T; Kondo T; Nakamura N; Yamashita H; Urata Y; Ashihara T; Katoh R
Cytometry; 2002 Nov; 49(3):91-5. PubMed ID: 12442308
[TBL] [Abstract][Full Text] [Related]
4. Relationship between histopathologic typing and morphonuclear assessments of 238 thyroid lesions. Digital cell image analysis performed on Feulgen-stained nuclei from formalin-fixed, paraffin-embedded materials.
Salmon I; Gasperin P; Pasteels JL; Heimann R; Kiss R
Am J Clin Pathol; 1992 Jun; 97(6):776-86. PubMed ID: 1375804
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
6. Morphometry in the cytologic evaluation of thyroid follicular lesions.
Nagashima T; Suzuki M; Oshida M; Hashimoto H; Yagata H; Shishikura T; Koda K; Nakajima N
Cancer; 1998 Apr; 84(2):115-8. PubMed ID: 9570215
[TBL] [Abstract][Full Text] [Related]
7. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
[TBL] [Abstract][Full Text] [Related]
8. [Thyrocyte morphomethric analysis significance in differential diagnosis of thyroid carcinoma].
Janković SK; Andjelković Z; Cerović S; Milosavljević I
Vojnosanit Pregl; 2011 Aug; 68(8):669-75. PubMed ID: 21991790
[TBL] [Abstract][Full Text] [Related]
9. Computerized morphometric study on fine needle aspirates of cellular follicular lesions of the thyroid.
Tseleni-Balafouta S; Kavantzas N; Paraskevakou H; Davaris P
Anal Quant Cytol Histol; 2000 Aug; 22(4):323-6. PubMed ID: 10965408
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of preoperative DNA measurement on FNA in benign and malignant thyroid neoplasm.
Perigli G; Cicchi P; Cianchi F; Artusi R; Olivari D; Caldini A; Cortesini C
J Exp Clin Cancer Res; 1998 Mar; 17(1):113-6. PubMed ID: 9646245
[No Abstract] [Full Text] [Related]
11. Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors.
Deprez C; Vangansbeke D; Fastrez R; Pasteels JL; Verhest A; Kiss R
Am J Clin Pathol; 1993 May; 99(5):558-65. PubMed ID: 8493949
[TBL] [Abstract][Full Text] [Related]
12. Image cytometry of fine needle aspiration of thyroid epithelial lesions.
Mahfouz SM; El-Sharkawy SL; Sharaf WM; El-din Hussein H; El-Nemr RS
Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):25-30. PubMed ID: 21691199
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
[TBL] [Abstract][Full Text] [Related]
14. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma.
Elsheikh TM; Asa SL; Chan JK; DeLellis RA; Heffess CS; LiVolsi VA; Wenig BM
Am J Clin Pathol; 2008 Nov; 130(5):736-44. PubMed ID: 18854266
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
[TBL] [Abstract][Full Text] [Related]
16. Comparison of morphonuclear features in normal, benign and neoplastic thyroid tissue by digital cell image analysis.
Salmon I; Kiss R; Franc B; Gasperin P; Heimann R; Pasteels JL; Verhest A
Anal Quant Cytol Histol; 1992 Feb; 14(1):47-54. PubMed ID: 1558615
[TBL] [Abstract][Full Text] [Related]
17. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
18. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.
Kelman AS; Rathan A; Leibowitz J; Burstein DE; Haber RS
Thyroid; 2001 Mar; 11(3):271-7. PubMed ID: 11327619
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma.
Saggiorato E; Cappia S; De Giuli P; Mussa A; Pancani G; Caraci P; Angeli A; Orlandi F
J Clin Endocrinol Metab; 2001 Nov; 86(11):5152-8. PubMed ID: 11701669
[TBL] [Abstract][Full Text] [Related]
20. DNA aneuploidy as a specific marker of neoplastic cells in FNAB of the thyroid.
Nadjari B; Motherby H; Pooschke T; Pooschke S; Gabbert HE; Simon D; Röher HD; Feldkamp J; Tharandt L; Böcking A
Anal Quant Cytol Histol; 1999 Dec; 21(6):481-8. PubMed ID: 10626017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
